[Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia].
A case of essential thrombocytemia treated with alpha interferon is reported, with hematological remission, but as a side effect hypertriglyceridemia is relevant. It was normalized when alpha interferon was stopped. This is the first case of essential thrombocythemia in Venezuela treated with biological modifiers, with hematological remission, but with hypertriglyceridemia as side effect.
De Salvo
L
L
Instituto Hematológico de Occidente, Banco de Sangre, Maracaibo, Venezuela.
Plumacher
Z
Z
Gómez
O
O
Weir-Medina
J
J
Paz
L
L
Salas
D
D
D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D012074:Remission Induction; D013920:Thrombocythemia, Essential / Q000097:blood / Q000628:therapy*
D007155:Immunologic Factors; D016898:Interferon-alpha; D000493:Allopurinol; D006918:Hydroxyurea